Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine
依非韦伦的药代动力学及接受含每日高剂量利福喷丁的结核病治疗的患者中人类免疫缺陷病毒1型(HIV-1)的病毒抑制情况
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciab1037
Podany, Anthony T; Pham, Michelle; Sizemore, Erin; Martinson, Neil; Samaneka, Wadzanai; Mohapi, Lerato; Badal-Faesen, Sharlaa; Dawson, Rod; Johnson, John L; Mayanja, Harriet; Lalloo, Umesh; Whitworth, William C; Pettit, April; Campbell, Kayla; Phillips, Patrick P J; Bryant, Kia; Scott, Nigel; Vernon, Andrew; Kurbatova, Ekaterina V; Chaisson, Richard E; Dorman, Susan E; Nahid, Payam; Swindells, Susan; Dooley, Kelly E; Fletcher, Courtney V